Phenominer Database Results (21 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Clinical Measurement Notes Record ID Study ID
SS-Chr 5BN/Mcwi percentage of study population developing mammary tumors during a period of time 7,12-dimethyltetraphene (DMBA) (65 g/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 13 54.0 % manual palpation method 0 DMBA oral gavage 105 days 200 mg DMBA in 10 ml seame oil 11493 86
SS/JrHsdMcwi post-insult time to mammary tumor formation 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 40 79.8 d 0.59 3.71 manual palpation method 0 DMBA oral gavage 105 days 200ng DMBA/10 ml seasme oil 65568 86
SS-Chr 14BN/Mcwi post-insult time to mammary tumor formation 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 14 46.69 d 1.09 4.06 manual palpation method 0 DMBA oral gavage 105 days 200 mg DMBA in 10 ml seame oil 65570 86
SS.BN-(D6Rat149-D6Rat18)/Mcwi ratio of deaths related to DMBA toxicity to total study population during a period of time 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 total life span female 152 days-162 days 15 80.0 % necropsy 0 DMBA oral gavage 105 days ratio of deaths related to DMBA toxicity to total study population during a period of time (CMO:0003809) 65576 86
SS.BN-(D6Rat149-D6Got171)/Mcwi ratio of deaths related to DMBA toxicity to total study population during a period of time 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 total life span female 152 days-162 days 15 40.0 % necropsy 0 DMBA oral gavage 105 days ratio of deaths related to DMBA toxicity to total study population during a period of time (CMO:0003809) 65577 86
SS.BN-(D13Hmgc64-RN34_13048990782)/Mcwi mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 14 4.86 null 0.7 2.63 necropsy 0 DMBA oral gavage 105 days necropsy 65573 86
SS-Chr 3BN/Mcwi percentage of study population developing mammary tumors during a period of time 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 14 29.0 % manual palpation method 0 DMBA oral gavage 105 days 200 mg DMBA in 10 ml seame oil 65566 86
SS.BN-(D6Rat149-D6Arb3)/Mcwi mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 14 4.77 null 0.64 2.39 necropsy 0 DMBA oral gavage 105 days necropsy 65571 86
SS.BN-(D13Hmgc64-RN34_13048990782)/Mcwi post-insult time to mammary tumor formation 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 14 48.51 d 12.07 45.15 manual palpation method 0 DMBA oral gavage 105 days 200ng DMBA/10 ml seasme oil 65572 86
SS-Chr 9BN/Mcwi percentage of study population developing mammary tumors during a period of time 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 40 93.0 % manual palpation method 0 DMBA oral gavage 105 days 200 mg DMBA in 10 ml seame oil 11495 86
SS-Chr 6BN/Mcwi ratio of deaths related to DMBA toxicity to total study population during a period of time 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 total life span female 152 days-162 days 20 95.0 % necropsy 0 DMBA oral gavage 105 days ratio of deaths related to DMBA toxicity to total study population during a period of time (CMO:0003809) 65578 86
SS-Chr 6BN/Mcwi percentage of study population developing mammary tumors during a period of time 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 20 20.0 % manual palpation method 0 DMBA oral gavage 105 days 200 mg DMBA in 10 ml seame oil 11494 86
SS.BN-(D6Rat149-D6Arb3)/Mcwi ratio of deaths related to DMBA toxicity to total study population during a period of time 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 total life span female 152 days-162 days 14 57.0 % necropsy 0 DMBA oral gavage 105 days ratio of deaths related to DMBA toxicity to total study population during a period of time (CMO:0003809) 65575 86
SS-Chr 9BN/Mcwi post-insult time to mammary tumor formation 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 40 58.31 d 0.85 5.39 manual palpation method 0 DMBA oral gavage 105 days 200 mg DMBA in 10 ml seame oil 65567 86
SS-Chr 3BN/Mcwi post-insult time to mammary tumor formation 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 14 95.48 d 1.67 6.23 manual palpation method 0 DMBA oral gavage 105 days 200 mg DMBA in 10 ml seame oil 11491 86
SS-Chr 16BN/Mcwi mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 13 6.31 null 1.61 5.79 necropsy 0 DMBA oral gavage 105 days necropsy 11504 86
SS/JrHsdMcwi mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 40 2.45 null 0.21 1.32 necropsy 0 DMBA oral gavage 105 days necropsy 11488 86
SS-Chr 13BN/Mcwi mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 13 5.33 null 1.21 4.38 necropsy 0 DMBA oral gavage 105 days necropsy 11501 86
SS.BN-(D6Rat149-D6Arb3)/Mcwi post-insult time to mammary tumor formation 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 14 52.37 d 1.32 4.94 manual palpation method 0 DMBA oral gavage 105 days 200ng DMBA/10 ml seasme oil 65574 86
SS-Chr 19BN/Mcwi post-insult time to mammary tumor formation 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 14 44.03 d 0.41 1.54 manual palpation method 0 DMBA oral gavage 105 days 200 mg DMBA in 10 ml seame oil 65569 86
SS-Chr 19BN/Mcwi mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 mammary gland integrity trait female 152 days-162 days 14 8.79 null 1.25 4.68 necropsy 0 DMBA oral gavage 105 days necropsy 11507 86